nodes	percent_of_prediction	percent_of_DWPC	metapath
Yohimbine—SLC6A4—conduct disorder	0.498	0.565	CbGaD
Yohimbine—HTR2A—conduct disorder	0.383	0.434	CbGaD
Yohimbine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000177	0.00149	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR ligand binding—CGA—conduct disorder	0.000174	0.00147	CbGpPWpGaD
Yohimbine—HTR1F—GPCR ligand binding—HTR2A—conduct disorder	0.00017	0.00143	CbGpPWpGaD
Yohimbine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000169	0.00142	CbGpPWpGaD
Yohimbine—HTR1D—GPCR downstream signaling—CGA—conduct disorder	0.000168	0.00141	CbGpPWpGaD
Yohimbine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000167	0.0014	CbGpPWpGaD
Yohimbine—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000166	0.0014	CbGpPWpGaD
Yohimbine—HTR1D—GPCR ligand binding—DRD4—conduct disorder	0.000166	0.0014	CbGpPWpGaD
Yohimbine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000165	0.00139	CbGpPWpGaD
Yohimbine—HTR1B—GPCR downstream signaling—CGA—conduct disorder	0.000164	0.00138	CbGpPWpGaD
Yohimbine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000164	0.00138	CbGpPWpGaD
Yohimbine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000163	0.00137	CbGpPWpGaD
Yohimbine—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000163	0.00137	CbGpPWpGaD
Yohimbine—HTR1B—GPCR ligand binding—DRD4—conduct disorder	0.000163	0.00137	CbGpPWpGaD
Yohimbine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000162	0.00136	CbGpPWpGaD
Yohimbine—ADRA2A—G alpha (i) signalling events—DRD4—conduct disorder	0.000161	0.00136	CbGpPWpGaD
Yohimbine—HTR2C—G alpha (q) signalling events—HTR2A—conduct disorder	0.00016	0.00134	CbGpPWpGaD
Yohimbine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000158	0.00133	CbGpPWpGaD
Yohimbine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000155	0.00131	CbGpPWpGaD
Yohimbine—HTR2B—GPCR downstream signaling—CGA—conduct disorder	0.000154	0.0013	CbGpPWpGaD
Yohimbine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000153	0.00129	CbGpPWpGaD
Yohimbine—HTR2B—GPCR ligand binding—DRD4—conduct disorder	0.000153	0.00129	CbGpPWpGaD
Yohimbine—ADRA1B—G alpha (q) signalling events—HTR2A—conduct disorder	0.000153	0.00129	CbGpPWpGaD
Yohimbine—HTR1D—Signaling by GPCR—CGA—conduct disorder	0.000152	0.00128	CbGpPWpGaD
Yohimbine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000149	0.00126	CbGpPWpGaD
Yohimbine—HTR1B—Signaling by GPCR—CGA—conduct disorder	0.000149	0.00126	CbGpPWpGaD
Yohimbine—HTR1F—GPCR downstream signaling—DRD4—conduct disorder	0.000147	0.00124	CbGpPWpGaD
Yohimbine—DRD3—GPCR downstream signaling—CGA—conduct disorder	0.000144	0.00121	CbGpPWpGaD
Yohimbine—ADRA1D—GPCR downstream signaling—CGA—conduct disorder	0.000144	0.00121	CbGpPWpGaD
Yohimbine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000143	0.0012	CbGpPWpGaD
Yohimbine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000143	0.0012	CbGpPWpGaD
Yohimbine—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000143	0.0012	CbGpPWpGaD
Yohimbine—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000142	0.0012	CbGpPWpGaD
Yohimbine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000142	0.0012	CbGpPWpGaD
Yohimbine—DRD3—GPCR ligand binding—DRD4—conduct disorder	0.000142	0.0012	CbGpPWpGaD
Yohimbine—ADRA1D—GPCR ligand binding—DRD4—conduct disorder	0.000142	0.0012	CbGpPWpGaD
Yohimbine—SLC6A4—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000141	0.00119	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—CGA—conduct disorder	0.000141	0.00118	CbGpPWpGaD
Yohimbine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000141	0.00118	CbGpPWpGaD
Yohimbine—HTR2B—Signaling by GPCR—CGA—conduct disorder	0.00014	0.00118	CbGpPWpGaD
Yohimbine—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00014	0.00117	CbGpPWpGaD
Yohimbine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000137	0.00115	CbGpPWpGaD
Yohimbine—HTR1F—Signaling by GPCR—DRD4—conduct disorder	0.000134	0.00112	CbGpPWpGaD
Yohimbine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000133	0.00112	CbGpPWpGaD
Yohimbine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000131	0.0011	CbGpPWpGaD
Yohimbine—DRD3—Signaling by GPCR—CGA—conduct disorder	0.00013	0.0011	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling by GPCR—CGA—conduct disorder	0.00013	0.0011	CbGpPWpGaD
Yohimbine—ADRA2B—GPCR downstream signaling—CGA—conduct disorder	0.00013	0.00109	CbGpPWpGaD
Yohimbine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000129	0.00108	CbGpPWpGaD
Yohimbine—ADRA2B—GPCR ligand binding—DRD4—conduct disorder	0.000129	0.00108	CbGpPWpGaD
Yohimbine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000128	0.00108	CbGpPWpGaD
Yohimbine—HTR1A—GPCR downstream signaling—CGA—conduct disorder	0.000125	0.00105	CbGpPWpGaD
Yohimbine—HTR2C—GPCR downstream signaling—CGA—conduct disorder	0.000125	0.00105	CbGpPWpGaD
Yohimbine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000124	0.00104	CbGpPWpGaD
Yohimbine—HTR1A—GPCR ligand binding—DRD4—conduct disorder	0.000124	0.00104	CbGpPWpGaD
Yohimbine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000123	0.00104	CbGpPWpGaD
Yohimbine—HTR2C—GPCR ligand binding—DRD4—conduct disorder	0.000123	0.00104	CbGpPWpGaD
Yohimbine—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000122	0.00103	CbGpPWpGaD
Yohimbine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000122	0.00103	CbGpPWpGaD
Yohimbine—ADRA2C—GPCR downstream signaling—CGA—conduct disorder	0.000121	0.00102	CbGpPWpGaD
Yohimbine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00012	0.00101	CbGpPWpGaD
Yohimbine—ADRA2C—GPCR ligand binding—DRD4—conduct disorder	0.00012	0.00101	CbGpPWpGaD
Yohimbine—ADRA1B—GPCR downstream signaling—CGA—conduct disorder	0.000119	0.001	CbGpPWpGaD
Yohimbine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000118	0.000994	CbGpPWpGaD
Yohimbine—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	0.000118	0.000994	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—CGA—conduct disorder	0.000118	0.000991	CbGpPWpGaD
Yohimbine—SLC6A4—Circadian rythm related genes—EP300—conduct disorder	0.000115	0.000969	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—CGA—conduct disorder	0.000114	0.000957	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—CGA—conduct disorder	0.000113	0.000952	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—WASF1—conduct disorder	0.000113	0.000949	CbGpPWpGaD
Yohimbine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00011	0.000927	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—CGA—conduct disorder	0.00011	0.000926	CbGpPWpGaD
Yohimbine—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.00011	0.000925	CbGpPWpGaD
Yohimbine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000109	0.000917	CbGpPWpGaD
Yohimbine—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.000109	0.000917	CbGpPWpGaD
Yohimbine—CYP2D6—Biological oxidations—COMT—conduct disorder	0.000109	0.000914	CbGpPWpGaD
Yohimbine—HTR1D—GPCR ligand binding—HTR2A—conduct disorder	0.000109	0.000913	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—CGA—conduct disorder	0.000108	0.000911	CbGpPWpGaD
Yohimbine—HTR2A—GPCR downstream signaling—CGA—conduct disorder	0.000108	0.00091	CbGpPWpGaD
Yohimbine—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.000108	0.000907	CbGpPWpGaD
Yohimbine—HTR2A—GPCR ligand binding—DRD4—conduct disorder	0.000107	0.000902	CbGpPWpGaD
Yohimbine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.000107	0.000901	CbGpPWpGaD
Yohimbine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000106	0.000894	CbGpPWpGaD
Yohimbine—HTR1B—GPCR ligand binding—HTR2A—conduct disorder	0.000106	0.000894	CbGpPWpGaD
Yohimbine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000106	0.00089	CbGpPWpGaD
Yohimbine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000103	0.000866	CbGpPWpGaD
Yohimbine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000101	0.000852	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—CGA—conduct disorder	9.98e-05	0.00084	CbGpPWpGaD
Yohimbine—HTR2B—GPCR ligand binding—HTR2A—conduct disorder	9.98e-05	0.00084	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	9.84e-05	0.000828	CbGpPWpGaD
Yohimbine—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	9.83e-05	0.000827	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—CGA—conduct disorder	9.82e-05	0.000826	CbGpPWpGaD
Yohimbine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.75e-05	0.000821	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	9.75e-05	0.00082	CbGpPWpGaD
Yohimbine—HTR1F—GPCR downstream signaling—HTR2A—conduct disorder	9.59e-05	0.000807	CbGpPWpGaD
Yohimbine—HTR1D—GPCR downstream signaling—DRD4—conduct disorder	9.4e-05	0.000791	CbGpPWpGaD
Yohimbine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.34e-05	0.000785	CbGpPWpGaD
Yohimbine—DRD3—GPCR ligand binding—HTR2A—conduct disorder	9.29e-05	0.000782	CbGpPWpGaD
Yohimbine—ADRA1D—GPCR ligand binding—HTR2A—conduct disorder	9.29e-05	0.000782	CbGpPWpGaD
Yohimbine—DRD3—Circadian rythm related genes—EP300—conduct disorder	9.21e-05	0.000775	CbGpPWpGaD
Yohimbine—HTR1B—GPCR downstream signaling—DRD4—conduct disorder	9.21e-05	0.000774	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—CGA—conduct disorder	9.01e-05	0.000758	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—CGA—conduct disorder	8.94e-05	0.000752	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—CGA—conduct disorder	8.82e-05	0.000742	CbGpPWpGaD
Yohimbine—HTR1F—Signaling by GPCR—HTR2A—conduct disorder	8.71e-05	0.000733	CbGpPWpGaD
Yohimbine—HTR2B—GPCR downstream signaling—DRD4—conduct disorder	8.65e-05	0.000727	CbGpPWpGaD
Yohimbine—HTR1D—Signaling by GPCR—DRD4—conduct disorder	8.54e-05	0.000718	CbGpPWpGaD
Yohimbine—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	8.49e-05	0.000715	CbGpPWpGaD
Yohimbine—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	8.39e-05	0.000706	CbGpPWpGaD
Yohimbine—HTR1B—Signaling by GPCR—DRD4—conduct disorder	8.36e-05	0.000703	CbGpPWpGaD
Yohimbine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.36e-05	0.000703	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—CGA—conduct disorder	8.28e-05	0.000697	CbGpPWpGaD
Yohimbine—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	8.1e-05	0.000681	CbGpPWpGaD
Yohimbine—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	8.06e-05	0.000678	CbGpPWpGaD
Yohimbine—DRD3—GPCR downstream signaling—DRD4—conduct disorder	8.05e-05	0.000677	CbGpPWpGaD
Yohimbine—ADRA1D—GPCR downstream signaling—DRD4—conduct disorder	8.05e-05	0.000677	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—DRD4—conduct disorder	7.89e-05	0.000663	CbGpPWpGaD
Yohimbine—HTR2B—Signaling by GPCR—DRD4—conduct disorder	7.85e-05	0.000661	CbGpPWpGaD
Yohimbine—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	7.83e-05	0.000659	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—CGA—conduct disorder	7.77e-05	0.000654	CbGpPWpGaD
Yohimbine—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	7.71e-05	0.000649	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—CGA—conduct disorder	7.71e-05	0.000648	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—CGA—conduct disorder	7.71e-05	0.000648	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling by GPCR—DRD4—conduct disorder	7.31e-05	0.000615	CbGpPWpGaD
Yohimbine—DRD3—Signaling by GPCR—DRD4—conduct disorder	7.31e-05	0.000615	CbGpPWpGaD
Yohimbine—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	7.26e-05	0.000611	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—WASF1—conduct disorder	7.22e-05	0.000607	CbGpPWpGaD
Yohimbine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	7.11e-05	0.000598	CbGpPWpGaD
Yohimbine—CYP3A4—Biological oxidations—COMT—conduct disorder	7.1e-05	0.000597	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—WASF1—conduct disorder	7.07e-05	0.000595	CbGpPWpGaD
Yohimbine—CYP3A4—Biological oxidations—MAOA—conduct disorder	7.05e-05	0.000593	CbGpPWpGaD
Yohimbine—DRD2—Circadian rythm related genes—EP300—conduct disorder	7.05e-05	0.000593	CbGpPWpGaD
Yohimbine—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	7.01e-05	0.00059	CbGpPWpGaD
Yohimbine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	7e-05	0.000589	CbGpPWpGaD
Yohimbine—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	6.98e-05	0.000587	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—CGA—conduct disorder	6.96e-05	0.000585	CbGpPWpGaD
Yohimbine—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	6.79e-05	0.000571	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—CGA—conduct disorder	6.72e-05	0.000565	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—CGA—conduct disorder	6.68e-05	0.000562	CbGpPWpGaD
Yohimbine—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	6.68e-05	0.000562	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—WASF1—conduct disorder	6.64e-05	0.000558	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	6.6e-05	0.000555	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—CGA—conduct disorder	6.5e-05	0.000547	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—CGA—conduct disorder	6.4e-05	0.000538	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—DRD4—conduct disorder	6.37e-05	0.000536	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	6.36e-05	0.000535	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—DRD4—conduct disorder	6.34e-05	0.000533	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—CGA—conduct disorder	6.31e-05	0.000531	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—WASF1—conduct disorder	6.18e-05	0.00052	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—WASF1—conduct disorder	6.18e-05	0.00052	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	6.16e-05	0.000518	CbGpPWpGaD
Yohimbine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	6.16e-05	0.000518	CbGpPWpGaD
Yohimbine—HTR1D—GPCR downstream signaling—HTR2A—conduct disorder	6.13e-05	0.000516	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	6.06e-05	0.00051	CbGpPWpGaD
Yohimbine—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	6.06e-05	0.00051	CbGpPWpGaD
Yohimbine—HTR1B—GPCR downstream signaling—HTR2A—conduct disorder	6.01e-05	0.000505	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—CGA—conduct disorder	5.9e-05	0.000496	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—CGA—conduct disorder	5.8e-05	0.000488	CbGpPWpGaD
Yohimbine—HTR2B—GPCR downstream signaling—HTR2A—conduct disorder	5.64e-05	0.000475	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—DRD4—conduct disorder	5.59e-05	0.00047	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—WASF1—conduct disorder	5.58e-05	0.000469	CbGpPWpGaD
Yohimbine—HTR1D—Signaling by GPCR—HTR2A—conduct disorder	5.57e-05	0.000469	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	5.51e-05	0.000464	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—DRD4—conduct disorder	5.5e-05	0.000463	CbGpPWpGaD
Yohimbine—HTR1B—Signaling by GPCR—HTR2A—conduct disorder	5.45e-05	0.000459	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—WASF1—conduct disorder	5.38e-05	0.000453	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—WASF1—conduct disorder	5.36e-05	0.000451	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—CGA—conduct disorder	5.28e-05	0.000444	CbGpPWpGaD
Yohimbine—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	5.25e-05	0.000442	CbGpPWpGaD
Yohimbine—ADRA1D—GPCR downstream signaling—HTR2A—conduct disorder	5.25e-05	0.000442	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—WASF1—conduct disorder	5.21e-05	0.000438	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—HTR2A—conduct disorder	5.15e-05	0.000433	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—WASF1—conduct disorder	5.13e-05	0.000431	CbGpPWpGaD
Yohimbine—HTR2B—Signaling by GPCR—HTR2A—conduct disorder	5.12e-05	0.000431	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—DRD4—conduct disorder	5.04e-05	0.000424	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	5.01e-05	0.000421	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—DRD4—conduct disorder	4.94e-05	0.000415	CbGpPWpGaD
Yohimbine—DRD3—Signaling by GPCR—HTR2A—conduct disorder	4.77e-05	0.000401	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling by GPCR—HTR2A—conduct disorder	4.77e-05	0.000401	CbGpPWpGaD
Yohimbine—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	4.74e-05	0.000399	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—WASF1—conduct disorder	4.73e-05	0.000398	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—WASF1—conduct disorder	4.65e-05	0.000391	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—DRD4—conduct disorder	4.64e-05	0.00039	CbGpPWpGaD
Yohimbine—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	4.58e-05	0.000385	CbGpPWpGaD
Yohimbine—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	4.55e-05	0.000383	CbGpPWpGaD
Yohimbine—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	4.43e-05	0.000372	CbGpPWpGaD
Yohimbine—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	4.36e-05	0.000367	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—DRD4—conduct disorder	4.32e-05	0.000363	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—DRD4—conduct disorder	4.32e-05	0.000363	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	4.3e-05	0.000362	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—WASF1—conduct disorder	4.23e-05	0.000356	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	4.16e-05	0.00035	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	4.13e-05	0.000348	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—CGA—conduct disorder	4.11e-05	0.000346	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	4.02e-05	0.000338	CbGpPWpGaD
Yohimbine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	4.02e-05	0.000338	CbGpPWpGaD
Yohimbine—ADRA2B—Hemostasis—EP300—conduct disorder	3.97e-05	0.000334	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	3.96e-05	0.000333	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—DRD4—conduct disorder	3.9e-05	0.000328	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—DRD4—conduct disorder	3.76e-05	0.000316	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—DRD4—conduct disorder	3.74e-05	0.000315	CbGpPWpGaD
Yohimbine—ADRA2C—Hemostasis—EP300—conduct disorder	3.71e-05	0.000312	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	3.65e-05	0.000307	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—DRD4—conduct disorder	3.64e-05	0.000306	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	3.6e-05	0.000303	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—DRD4—conduct disorder	3.58e-05	0.000301	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—COMT—conduct disorder	3.51e-05	0.000295	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—MAOA—conduct disorder	3.48e-05	0.000293	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—DRD4—conduct disorder	3.3e-05	0.000278	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—HTR2A—conduct disorder	3.29e-05	0.000277	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	3.27e-05	0.000275	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—DRD4—conduct disorder	3.25e-05	0.000273	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—HTR2A—conduct disorder	3.22e-05	0.000271	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—HTR2A—conduct disorder	3.03e-05	0.000255	CbGpPWpGaD
Yohimbine—ADRA2A—Hemostasis—EP300—conduct disorder	3.01e-05	0.000254	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—DRD4—conduct disorder	2.96e-05	0.000249	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—COMT—conduct disorder	2.85e-05	0.00024	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—MAOA—conduct disorder	2.83e-05	0.000238	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—HTR2A—conduct disorder	2.82e-05	0.000237	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—HTR2A—conduct disorder	2.82e-05	0.000237	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—EP300—conduct disorder	2.73e-05	0.000229	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CGA—conduct disorder	2.69e-05	0.000226	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	2.54e-05	0.000214	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—HTR2A—conduct disorder	2.45e-05	0.000206	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—HTR2A—conduct disorder	2.44e-05	0.000205	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	2.38e-05	0.0002	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	2.34e-05	0.000197	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—HTR2A—conduct disorder	2.16e-05	0.000181	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	1.93e-05	0.000162	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—COMT—conduct disorder	1.86e-05	0.000156	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—MAOA—conduct disorder	1.84e-05	0.000155	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—EP300—conduct disorder	1.74e-05	0.000147	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—EP300—conduct disorder	1.71e-05	0.000144	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—EP300—conduct disorder	1.6e-05	0.000135	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—EP300—conduct disorder	1.5e-05	0.000127	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—EP300—conduct disorder	1.49e-05	0.000126	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—EP300—conduct disorder	1.49e-05	0.000126	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—EP300—conduct disorder	1.35e-05	0.000113	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—EP300—conduct disorder	1.3e-05	0.000109	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—EP300—conduct disorder	1.29e-05	0.000109	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—EP300—conduct disorder	1.26e-05	0.000106	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—EP300—conduct disorder	1.24e-05	0.000104	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—EP300—conduct disorder	1.22e-05	0.000103	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—COMT—conduct disorder	1.21e-05	0.000102	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—MAOA—conduct disorder	1.21e-05	0.000101	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—EP300—conduct disorder	1.14e-05	9.6e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—EP300—conduct disorder	1.12e-05	9.45e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—EP300—conduct disorder	1.02e-05	8.6e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—EP300—conduct disorder	7.97e-06	6.7e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—EP300—conduct disorder	5.21e-06	4.38e-05	CbGpPWpGaD
